List of works - Ying Liu

A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells.

scientific article published on 4 October 2006

A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapy

scientific article

Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver

scientific article published on 14 February 2007

Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity

scientific article

Biodistribution and safety profile of recombinant adeno-associated virus serotype 6 vectors following intravenous delivery.

scientific article published on 14 May 2008

Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses.

scientific article

Comparison of adenoviruses from species B, C, E, and F after intravenous delivery

scientific article published on 25 September 2007

Controlled Extracellular Matrix Degradation in Breast Cancer Tumors Improves Therapy by Trastuzumab ⬇️

scientific article published on November 16, 2010

Correction: Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity.

scientific article published on 11 February 2011

Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14.

scientific article

Epithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenoviruses

scientific article published on 02 June 2009

In situ adenovirus vaccination engages T effector cells against cancer

scientific article published on 16 April 2009

In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46

scientific article

Toward a stem cell gene therapy for breast cancer

scientific article published on 27 March 2009

Transduction of liver metastases after intravenous injection of Ad5/35 or Ad35 vectors with and without factor X-binding protein pretreatment

scientific article

Transient removal of CD46 is safe and increases B-cell depletion by rituximab in CD46 transgenic mice and macaques

scientific article published on 23 October 2012

List of works by Ying Liu

A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells.

A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapy

Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver

Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity

Biodistribution and safety profile of recombinant adeno-associated virus serotype 6 vectors following intravenous delivery.

Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses.

Comparison of adenoviruses from species B, C, E, and F after intravenous delivery

Controlled Extracellular Matrix Degradation in Breast Cancer Tumors Improves Therapy by Trastuzumab ⬇️

Correction: Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity.

Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14.

Epithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenoviruses

In situ adenovirus vaccination engages T effector cells against cancer

In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46

Toward a stem cell gene therapy for breast cancer

Transduction of liver metastases after intravenous injection of Ad5/35 or Ad35 vectors with and without factor X-binding protein pretreatment

Transient removal of CD46 is safe and increases B-cell depletion by rituximab in CD46 transgenic mice and macaques